Reversible dementia due to thalidomide therapy for multiple myeloma

被引:12
作者
Morgan, AE [1 ]
Smith, WK [1 ]
Levenson, JL [1 ]
机构
[1] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23298 USA
关键词
D O I
10.1056/NEJM200305013481822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1821 / 1822
页数:2
相关论文
共 3 条
[1]   Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications [J].
Mitsiades, N ;
Mitsiades, CS ;
Poulaki, V ;
Chauhan, D ;
Richardson, PG ;
Hideshima, T ;
Munshi, NC ;
Treon, SP ;
Anderson, KC .
BLOOD, 2002, 99 (12) :4525-4530
[2]   Angiogenesis in hematologic malignancies [J].
Moehler, TM ;
Neben, K ;
Ho, AD ;
Goldschmidt, H .
ANNALS OF HEMATOLOGY, 2001, 80 (12) :695-705
[3]   Thalidomide alone or with dexamethasone for previously untreated multiple myeloma [J].
Weber, D ;
Rankin, K ;
Gavino, M ;
Delasalle, K ;
Alexanian, R .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :16-19